By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Research and development, manufacturing, commercialization and sale of innovative medicines and106.47M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States106.47M100.00%